Dietary Interventions in Ulcerative Colitis: A Systematic Review of the Evidence with Meta-Analysis

Nutrients. 2023 Sep 28;15(19):4194. doi: 10.3390/nu15194194.

Abstract

(1) Background: Ulcerative colitis (UC) is a chronic colon inflammation caused by genetic and environmental factors, including diet. This systematic review and meta-analysis aims to assess the impact of diet on UC management in children and adults (2) Methods: A comprehensive search across databases yielded relevant studies, and risk of bias in randomized controlled trials (RCTs) was assessed using the Cochrane Risk of Bias tool. This study was conducted in conformity to the 2020 PRISMA guidelines. The certainty of evidence for outcomes was evaluated using GRADE methodology. Meta-analysis was performed using Review Manager software version 5.4. (3) Results: Fourteen RCTs were included, results indicated higher clinical response, remission, and endoscopic remission rates in diet-treated groups. Carrageenan-free, anti-inflammatory, and cow milk protein elimination diets showed no significant advantages in maintaining clinical remission. However, a study involving fermented cow milk with bifidobacterial demonstrated favorable outcomes. Overall, pooled analysis leaned in favor of dietary intervention for sustaining clinical remission; (4) Conclusions: The relationship between diet and UC is an evolving terrain that demands deeper exploration. This systematic review and meta-analysis highlight the evolving relationship between diet and UC, necessitating further exploration. While understanding grows, adopting personalized dietary approaches could alleviate symptoms, and support a more positive disease trajectory.

Keywords: Crohn’s disease; children; diet; exclusion diet; inflammatory bowel disease; ulcerative colitis.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Child
  • Colitis, Ulcerative* / drug therapy
  • Humans
  • Inflammation / drug therapy
  • Remission Induction

Substances

  • Anti-Inflammatory Agents, Non-Steroidal

Grants and funding

The APC was funded by Nestlé Health Science. The authors assure that this source of funding does not influence either the research or its conclusions in any way. The research has been conducted independently and objectively, regardless of the source of funding.